JP2008542311A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542311A5
JP2008542311A5 JP2008513928A JP2008513928A JP2008542311A5 JP 2008542311 A5 JP2008542311 A5 JP 2008542311A5 JP 2008513928 A JP2008513928 A JP 2008513928A JP 2008513928 A JP2008513928 A JP 2008513928A JP 2008542311 A5 JP2008542311 A5 JP 2008542311A5
Authority
JP
Japan
Prior art keywords
peg
polypeptide
csf
regioisomers
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008513928A
Other languages
English (en)
Japanese (ja)
Other versions
JP5137821B2 (ja
JP2008542311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2006/000292 external-priority patent/WO2006128460A2/en
Publication of JP2008542311A publication Critical patent/JP2008542311A/ja
Publication of JP2008542311A5 publication Critical patent/JP2008542311A5/ja
Application granted granted Critical
Publication of JP5137821B2 publication Critical patent/JP5137821B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008513928A 2005-06-01 2006-05-26 Ｐｅｇ化されたｇ−ｃｓｆポリペプチドおよびその製造方法 Expired - Fee Related JP5137821B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68672605P 2005-06-01 2005-06-01
US60/686,726 2005-06-01
PCT/DK2006/000292 WO2006128460A2 (en) 2005-06-01 2006-05-26 Pegylated g-csf polypeptides and methods of producing same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012173959A Division JP2013010765A (ja) 2005-06-01 2012-08-06 Ｐｅｇ化されたｇ−ｃｓｆポリペプチドおよびその製造方法

Publications (3)

Publication Number Publication Date
JP2008542311A JP2008542311A (ja) 2008-11-27
JP2008542311A5 true JP2008542311A5 (https=) 2009-01-15
JP5137821B2 JP5137821B2 (ja) 2013-02-06

Family

ID=37308965

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008513928A Expired - Fee Related JP5137821B2 (ja) 2005-06-01 2006-05-26 Ｐｅｇ化されたｇ−ｃｓｆポリペプチドおよびその製造方法
JP2012173959A Pending JP2013010765A (ja) 2005-06-01 2012-08-06 Ｐｅｇ化されたｇ−ｃｓｆポリペプチドおよびその製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012173959A Pending JP2013010765A (ja) 2005-06-01 2012-08-06 Ｐｅｇ化されたｇ−ｃｓｆポリペプチドおよびその製造方法

Country Status (16)

Country Link
US (5) US7381805B2 (https=)
EP (1) EP1888119B1 (https=)
JP (2) JP5137821B2 (https=)
KR (1) KR20080027291A (https=)
CN (1) CN101193658B (https=)
AT (1) ATE500847T1 (https=)
AU (1) AU2006254543A1 (https=)
BR (1) BRPI0611221A2 (https=)
CA (1) CA2607844C (https=)
DE (1) DE602006020562D1 (https=)
IL (1) IL187009A0 (https=)
MX (1) MX2007015156A (https=)
NO (1) NO20075708L (https=)
RU (1) RU2007149238A (https=)
WO (1) WO2006128460A2 (https=)
ZA (1) ZA200709704B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1888119B1 (en) 2005-06-01 2011-03-09 Maxygen, Inc. Pegylated g-csf polypeptides and methods of producing same
DE202008017456U1 (de) * 2007-08-27 2009-08-27 Biogenerix Ag Flüssig-Formulierung von G-CSF-Konjugaten
CN102215876A (zh) * 2008-09-19 2011-10-12 马克西根公司 通过施用多peg化的粒细胞集落刺激因子(g-csf)变体来治疗辐射诱发的嗜中性细胞减少症的方法
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
WO2011041376A1 (en) * 2009-09-30 2011-04-07 Prolong Pharmaceuticals Modified granulocyte colony stimulating factor (g-csf)
EP2494050A4 (en) * 2009-10-30 2013-10-30 Merck Sharp & Dohme GRANULOCYTIC COLONY STIMULATING FACTOR MADE IN GLYCOENGINEERED PICHIA PASTORIS
TWI480288B (zh) * 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
WO2012064845A2 (en) * 2010-11-09 2012-05-18 Nektar Therapeutics G-csf polymer conjugates having a releasable linkage
EP2709669A1 (en) 2011-05-17 2014-03-26 Bristol-Myers Squibb Company Methods for maintaining pegylation of polypeptides
CN104109199B (zh) * 2013-04-16 2019-04-30 深圳未名新鹏生物医药有限公司 一种聚乙二醇单修饰的人粒细胞集落刺激因子的制备方法及其产品
JP2018519359A (ja) * 2015-06-11 2018-07-19 アンビオ ファーマシューティカルズ，エルエルシー Ｐｅｇ化顆粒球コロニー刺激因子（ｇｃｓｆ）
KR102020995B1 (ko) * 2017-10-30 2019-09-16 한국코러스 주식회사 콜로니자극인자와 폴리올이 접합된 접합물을 고수율로 제조하는 방법
WO2020118136A1 (en) * 2018-12-06 2020-06-11 Board Of Regents, The University Of Texas System Selectively cleavable therapeutic nanoparticles
CN114853872B (zh) * 2022-04-27 2023-11-17 山东新时代药业有限公司 一种聚乙二醇修饰rhG-CSF的制备方法

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US588025A (en) * 1897-08-10 Furnace-door-operating device
AU631312B (en) 1912-09-04 1913-09-16 Aage Philip Heyman Improvements in and relating; to milking; machines
WO1985000817A1 (en) 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
JPS61227526A (ja) 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
EP0215126B1 (en) 1985-02-08 1991-07-31 Chugai Seiyaku Kabushiki Kaisha Human granulocyte colony stimulating factor
US6004548A (en) 1985-08-23 1999-12-21 Amgen, Inc. Analogs of pluripotent granulocyte colony-stimulating factor
JPS63500636A (ja) 1985-08-23 1988-03-10 麒麟麦酒株式会社 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
JPS6263335A (ja) 1985-09-13 1987-03-20 Fuji Photo Film Co Ltd 化学反応情報の処理方法
DE3681551D1 (de) 1985-09-30 1991-10-24 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
CA1297004C (en) 1986-01-22 1992-03-10 Masahiko Tamura Pharmaceutical agent for promoting the recovery of hemopoietic capacity
US4908773A (en) 1987-04-06 1990-03-13 Genex Corporation Computer designed stabilized proteins and method for producing same
DK203187A (da) 1986-04-22 1987-10-23 Immunex Corp Human g-csf proteinekspression
AU7675487A (en) 1986-08-11 1988-05-19 Cetus Corporation Expression of granulocyte colony-stimulating factor
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
DK174044B1 (da) 1986-12-23 2002-05-06 Kyowa Hakko Kogyo Kk Polypeptid afledt fra human granulocytkolonistimulerende faktor, og fremgangsmåde til fremstilling deraf, DNA kodende for nævnte polypeptid, rekombinant plasmid indeholdende nævnte DNA, og mikroorganismer indeholdende nævnte rekombinante plasmid.......
US5362853A (en) 1986-12-23 1994-11-08 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
US5714581A (en) 1986-12-23 1998-02-03 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
US5214132A (en) 1986-12-23 1993-05-25 Kyowa Hakko Kogyo Co., Ltd. Polypeptide derivatives of human granulocyte colony stimulating factor
US4853871A (en) 1987-04-06 1989-08-01 Genex Corporation Computer-based method for designing stablized proteins
GB2213821B (en) 1987-12-23 1992-01-02 British Bio Technology Synthetic human granulocyte colony stimulating factor gene
US4904584A (en) 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
CA1340810C (en) 1988-03-31 1999-11-02 Motoo Yamasaki Polypeptide derivatives of human granulocyte colony stimulating factor
JP2796388B2 (ja) 1988-05-13 1998-09-10 アムジエン・インコーポレーテツド Ｇ−ｃｓｆの精製方法
EP0344796B1 (en) 1988-06-03 1994-09-21 Chugai Seiyaku Kabushiki Kaisha Crystalline human granulocyte colony stimulating factor and process for preparing the same
US5025388A (en) 1988-08-26 1991-06-18 Cramer Richard D Iii Comparative molecular field analysis (CoMFA)
US5218092A (en) 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
US5349052A (en) 1988-10-20 1994-09-20 Royal Free Hospital School Of Medicine Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
US5104651A (en) 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
EP0401384B1 (en) * 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US20020177688A1 (en) * 1988-12-22 2002-11-28 Kirin-Amgen, Inc., Chemically-modified G-CSF
US6166183A (en) 1992-11-30 2000-12-26 Kirin-Amgen, Inc. Chemically-modified G-CSF
US5166322A (en) 1989-04-21 1992-11-24 Genetics Institute Cysteine added variants of interleukin-3 and chemical modifications thereof
US5109119A (en) 1989-06-06 1992-04-28 Schering Corporation Crystalline r-h-gm-csf and method
IE66494B1 (en) 1989-09-26 1996-01-10 Immunex Corp Granulocyte-colony stimulating factor receptors
EP0648501A1 (en) 1989-10-10 1995-04-19 Amgen Inc. Compositions comprising G-CSF for treating or preventing infections in canine and feline animals
US5265030A (en) 1990-04-24 1993-11-23 Scripps Clinic And Research Foundation System and method for determining three-dimensional structures of proteins
GB9107846D0 (en) 1990-04-30 1991-05-29 Ici Plc Polypeptides
US5399345A (en) 1990-05-08 1995-03-21 Boehringer Mannheim, Gmbh Muteins of the granulocyte colony stimulating factor
DE4014750A1 (de) 1990-05-08 1991-11-14 Boehringer Mannheim Gmbh Muteine des granulozyten-stimulierenden faktors (g-csf)
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
IE912365A1 (en) 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DK0546124T4 (da) 1990-08-29 2003-05-19 Inst Genetics Llc Hæmatopoiese-stimulatorer med flere domæner
US5124297A (en) 1990-12-07 1992-06-23 Amoco Corporation Olefin polymerization and copolymerization catalyst
DE4105480A1 (de) 1991-02-21 1992-08-27 Boehringer Mannheim Gmbh Verbesserte aktivierung von rekombinanten proteinen
US6565841B1 (en) 1991-03-15 2003-05-20 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
US5157736A (en) 1991-04-19 1992-10-20 International Business Machines Corporation Apparatus and method for optical recognition of chemical graphics
JP3417558B2 (ja) 1991-05-10 2003-06-16 ジェネンテク，インコーポレイテッド 配位子作用薬および拮抗薬の選択
US5386507A (en) 1991-07-18 1995-01-31 Teig; Steven L. Computer graphics system for selectively modelling molecules and investigating the chemical and physical properties thereof
US5281698A (en) 1991-07-23 1994-01-25 Cetus Oncology Corporation Preparation of an activated polymer ester for protein conjugation
AU666866B2 (en) * 1991-08-30 1996-02-29 Fred Hutchinson Cancer Research Center Hybrid cytokines
JP2638359B2 (ja) 1991-11-26 1997-08-06 富士通株式会社 分子動力学法の拘束条件作成装置
EP0955365A3 (en) 1992-06-09 2000-12-20 Chiron Corporation Crystallization of M-CSF
ZA933926B (en) 1992-06-17 1994-01-03 Amgen Inc Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules
US6057133A (en) 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5772992A (en) 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US6153183A (en) 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
EP0672145B1 (en) 1992-11-24 2003-04-23 G.D. Searle & Co. Interleukin-3 (il-3) multiple mutation polypeptides
US5738849A (en) 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5424963A (en) 1992-11-25 1995-06-13 Photon Research Associates, Inc. Molecular dynamics simulation method and apparatus
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
DK0726778T3 (da) 1994-02-08 2001-09-24 Amgen Inc Oral administration af kemisk modificerede proteiner
ES2312166T3 (es) 1994-02-23 2009-02-16 Kyowa Hakko Kogyo Co., Ltd Acelerador del crecimiento plaquetario.
US5635599A (en) 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
JPH11500308A (ja) 1995-02-03 1999-01-12 ジー．ディー．サール アンド カンパニー 新規ｃ−ＭＰＬリガンド
US6017523A (en) 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
US6100070A (en) 1995-10-05 2000-08-08 G. D. Searle & Co. G-CSF receptor agonists
EP0870027A1 (en) 1995-10-05 1998-10-14 G.D. Searle & Co. Novel c-mpl receptor agonists
US6066318A (en) 1995-10-05 2000-05-23 G.D. Searle & Co. Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
AU717733B2 (en) 1995-10-05 2000-03-30 G.D. Searle & Co. Novel G-CSF receptor agonists
CN1590407A (zh) 1995-10-05 2005-03-09 G.D.瑟尔公司 多功能性造血受体激动剂
US5969105A (en) 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
NZ335382A (en) 1996-10-25 2001-03-30 Searle & Co Multi-functional chimeric hematopoietic polypeptides of IL-3, GCSF, Flt3L, EPO, stem cell factor, cmpl link with or without linker group consisting of Alanine, Glycine and/or Serine for treating autoimmune and tumour related diseases
US6660257B1 (en) 1996-10-25 2003-12-09 Pharmacia Corporation Circular permuteins of flt3 ligand
CA2284127A1 (en) 1997-04-11 1998-10-22 G.D. Searle & Co. Flt3 ligand chimeric proteins
KR100241257B1 (ko) 1997-05-22 2000-02-01 한승수 인체 과립구 콜로니 자극 인자 활성물질 및 그것의 제조방법
WO1998055500A1 (en) 1997-06-06 1998-12-10 Kyowa Hakko Kogyo Co., Ltd. Chemically modified polypeptides
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
US5985263A (en) 1997-12-19 1999-11-16 Enzon, Inc. Substantially pure histidine-linked protein polymer conjugates
US6451986B1 (en) 1998-06-22 2002-09-17 Immunex Corporation Site specific protein modification
EP1115854A1 (en) 1998-09-25 2001-07-18 G.D. Searle & Co. Method of producing permuteins by scanning permutagenesis
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
AU770131B2 (en) 1999-01-06 2004-02-12 Xencor, Inc. Nucleic acids and proteins corresponding to mutants of G-CSF with granulopoietic activity
JP2002540065A (ja) 1999-01-29 2002-11-26 アムジェン インコーポレーテッド Ｇｃｓｆコンジュゲート
JP2000319298A (ja) 1999-03-04 2000-11-21 Seibutsu Bunshi Kogaku Kenkyusho:Kk 蛋白質複合体の結晶、構造座標、及び構造座標の使用
KR100356140B1 (ko) 1999-07-08 2002-10-19 한미약품공업 주식회사 인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
US6831158B2 (en) 2000-01-10 2004-12-14 Maxygen Holdings Ltd. G-CSF conjugates
US6646110B2 (en) 2000-01-10 2003-11-11 Maxygen Holdings Ltd. G-CSF polypeptides and conjugates
SK11672002A3 (sk) * 2000-01-10 2002-12-03 Maxygen Holdings Ltd. Polypeptidový konjugát, spôsob jeho výroby, farmaceutický prostriedok s jeho obsahom a jeho použitie
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
EP1354045A2 (en) 2000-09-07 2003-10-22 Eli Lilly And Company Hyperglycosylated polypeptides
JP4799803B2 (ja) 2000-09-08 2011-10-26 マサチューセッツ インスティテュート オブ テクノロジー Ｇ−ｃｓｆアナログ組成物および方法
GB0022877D0 (en) 2000-09-18 2000-11-01 Isis Innovation Analogues
US20020142964A1 (en) 2000-11-02 2002-10-03 Nissen Torben Lauesgaard Single-chain polypeptides
WO2002036626A1 (en) * 2000-11-02 2002-05-10 Maxygen Aps Single-chain multimeric polypeptides
KR100861810B1 (ko) * 2000-12-11 2008-10-07 코닌클리즈케 필립스 일렉트로닉스 엔.브이. 신호 처리 장치 및 신호 처리 결과 공급 방법
PL371781A1 (en) * 2001-07-11 2005-06-27 Maxygen Holdings, Ltd. G-csf conjugates
EP1888119B1 (en) * 2005-06-01 2011-03-09 Maxygen, Inc. Pegylated g-csf polypeptides and methods of producing same

Similar Documents

Publication Publication Date Title
JP2008542311A5 (https=)
US20250223280A1 (en) Potent asgpr-binding compounds for the degradation of immunoglobulins and other proteins
KR100689212B1 (ko) Ｇｃｓｆ 결합체
CN103476933B (zh) 白介素1受体的拮抗剂
CA2607844A1 (en) Pegylated g-csf polypeptides and methods of producing same
KR101549457B1 (ko) 폴리에틸렌글리콜과 과립구 콜로니 자극인자(g-csf)의 신규 접합체
JP2005506317A5 (ja) Ｇ−ｃｓｆ結合体
US20240239828A1 (en) Mannose 6-phosphate or asgpr receptor binding compounds for the degradation of extracellular proteins
CN102215876A (zh) 通过施用多peg化的粒细胞集落刺激因子(g-csf)变体来治疗辐射诱发的嗜中性细胞减少症的方法
US9593151B2 (en) Use of fusion protein
US20240239841A1 (en) Peptide and method for treating pain using the same
ZA200700524B (en) Methods of healing wounds by administering human IL-18
JP2009513689A5 (https=)
Son et al. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group
Li et al. Comparison of bioactivities of monopegylated rhG-CSF with branched and linear mPEG
JP5225393B2 (ja) 水溶性高分子修飾ｇ−ｃｓｆ複合体
RU2423133C2 (ru) Конъюгат полиэтиленгликоля-г-ксф
TW201703793A (zh) 聚乙二醇化介白素-11之組合物及方法
EP0519976B1 (en) Neutrophil stimulating peptides
JP2014526440A5 (https=)
CN101381413A (zh) 一种修饰的重组人内皮抑素及其应用
EP4606389A1 (en) Unique pegylated granulocyte colony stimulating factor, methods of use and preparation thereof
RU2002115633A (ru) Конъюгаты интерферона
TW202604571A (zh) 選擇性treg刺激劑及其使用方法
RU2019124280A (ru) СХЕМА ЛЕЧЕНИЯ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ ФАБРИ С ИСПОЛЬЗОВАНИЕМ СТАБИЛИЗИРОВАННОЙ α-ГАЛАКТОЗИДАЗЫ